Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Seekwell Ltd. is active in the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action. This action is assigned to 1 distinct examiner and 1 distinct art unit.
MINCHELLA, KAITLYN L is the busiest examiner for this portfolio, managing 1 pending office action. This single figure constitutes the total pending workload for the company. The prosecution landscape is highly focused with no distribution across different examiners or units. This lack of complexity simplifies the monitoring of active matters.
The presence of 1 pending office action suggests a streamlined prosecution phase. Because only 1 distinct examiner is involved, the company can focus its resources on a single point of contact. Practitioners should prepare for the specific examination style of MINCHELLA, KAITLYN L to resolve the 1 pending action. The involvement of 1 distinct art unit confirms a narrow technical scope for the current filing.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MINCHELLA, KAITLYN L | 1 | 26.4% | +21.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18570279 | SCORING AND CLASSIFYING EXTRACTS FROM A NON-ANIMAL NATURAL EUKARYOTIC SOURCE | MINCHELLA, KAITLYN L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18570279 | SCORING AND CLASSIFYING EXTRACTS FROM A NON-ANIMAL NATURAL EUKARYOTIC SOURCE | MINCHELLA, KAITLYN L | — |
| Art Unit | Apps |
|---|---|
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18570279 | SCORING AND CLASSIFYING EXTRACTS FROM A NON-ANIMAL NATURAL EUKARYOTIC SOURCE | MINCHELLA, KAITLYN L | 1685 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSeekwell Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Kaitlyn L Minchella has the most, with 1 of Seekwell Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
